Summit Financial Wealth Advisors, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
Summit Financial Wealth Advisors, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$308,772
-17.0%
10,800
-12.6%
0.08%
-11.6%
Q2 2023$372,009
-6.9%
12,3550.0%0.09%
-9.5%
Q1 2023$399,684
+6.6%
12,355
-5.6%
0.10%
+4.4%
Q4 2022$375,016
-21.2%
13,085
-31.8%
0.09%
-33.6%
Q3 2022$476,000
-3.6%
19,185
-4.4%
0.14%
+16.1%
Q2 2022$494,000
-43.1%
20,073
-11.3%
0.12%
-32.6%
Q1 2022$868,000
+21.1%
22,623
-1.0%
0.18%
+25.9%
Q4 2021$717,000
+16.0%
22,853
+9.0%
0.14%
-0.7%
Q3 2021$618,000
-13.2%
20,9580.0%0.14%
-13.0%
Q2 2021$712,000
+118.4%
20,958
+131.6%
0.16%
+94.0%
Q1 2021$326,000
-17.3%
9,050
-10.0%
0.08%
-22.4%
Q4 2020$394,000
+44.9%
10,050
+42.6%
0.11%
+46.6%
Q3 2020$272,000
+2.6%
7,050
-29.8%
0.07%
-12.0%
Q1 2020$265,000
-91.5%
10,045
-90.6%
0.08%
-89.0%
Q4 2019$3,116,000
+2.0%
107,157
-5.4%
0.76%
+1.1%
Q3 2019$3,054,000
+2.1%
113,232
-3.2%
0.75%
+2.3%
Q2 2019$2,990,000
+5.2%
116,963
-9.1%
0.73%
-2.4%
Q1 2019$2,841,000128,7100.75%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders